5th Targeted Radiopharmaceuticals Summit Europe 2023 Berlin Marriott Hotel, Berlin

As investments, mergers and acquisitions in the TRP field increase, all eyes are looking towards novel targets and their scope in the development of the field. However, significant challenges still remain surrounding supply chain issues, isotope transportation, selecting the right target molecule to improve accuracy, and unanswered regulatory questions.

The 5th Targeted Radiopharmaceuticals Summit is bringing together 100+ industry leaders across radioligand development from pharma and biotech to discuss novel targets outside of PSMA, next generation radiopharma therapeutics, how to meet regulatory expectations regarding targeting molecule and isotopes and recent clinical updates. Discover how to optimally translate your product through the clinic and address critical supply challenges in the TRP space.

Join your peers from the likes of Novartis, Bristol-Myers Squibb, Bicycle Therapeutics, Fusion Pharmaceuticals and more as they evaluate brand new technologies and approaches to improve existing practices to reduce off-target toxicities, improve accuracy of targeting molecule, understand dosimetry and its applications in personalising therapy and explore combination therapies to improve efficacy of your TRP.